期刊文献+

骨修复材料聚磷酸钙晶型对其降解性能和细胞相容性的影响 被引量:3

Effect of crystal type on degradation and cell compatibility of calcium polyphosphate for bone repair
下载PDF
导出
摘要 背景:聚磷酸钙是具有生物活性、可生物降解性和适当力学性能的新型骨修复材料,但是晶型对它的降解性能和细胞相容性的影响罕见报道。目的:探索骨修复材料聚磷酸钙的晶型对其降解性能和细胞相容性的影响规律。设计、时间及地点:对比观察实验,于2005-12/2007-02在四川大学组织工程支架材料研究室完成。材料:通过控制保温温度,制备不同晶型的聚磷酸钙。方法:进行体外降解实验,用扫描电镜观察其形貌;进行细胞相容性实验,观察成骨细胞在浸提液和降解液中的生长情况。主要观察指标:不同晶型聚磷酸钙失重率,磷酸根浓度,骨细胞生长曲线,细胞增殖率,细胞毒性。结果:不同晶型聚磷酸钙的降解速率与磷酸根浓度增长速率一致,都是γ-聚磷酸钙>β-聚磷酸钙>α-聚磷酸钙。不同晶型聚磷酸钙的浸提液和降解液中细胞生长速率不同,在第6天时β-聚磷酸钙增殖率最高;浸提液和降解液中β-聚磷酸钙、α-聚磷酸钙细胞毒性均为0;γ-聚磷酸钙在前期细胞毒性为0,后期为1。结论:通过改变聚磷酸钙的晶型可以调节其降解速率;各种晶型聚磷酸钙具有良好的细胞相容性,其中β型聚磷酸钙促成骨细胞增殖最明显,可作为新型骨修复材料。 BACKGROUND: Calcium polyphosphate (CPP), which has the nature of bioactivity, biodegradation and proper mechanical property, is a novel material for bone repair. But until now, the effect of crystal type on its degradation and cell compatibility is still a question. OBJECTIVE: To explore the effect of crystal type on the degradation and cell compatibility of CPP for bone repair. DESIGN, TIME AND SETTING: Control observations were performed at the Laboratory of Tissue Engineering Scaffold Materials in Sichuan University from December 2005 to February 2007. MATERIALS: CPP with different crystal types was prepared by sintering at different temperature. METHODS: The degradation experiment was done in vitro. The sample was characterized by scanning electron microscope. The cell compatibility was studied by observing the growth of osteoblasts in the leaching liquor and degradation liquor. MAIN OUTCOME MEASURES: The weight loss of CPP with different crystal type was calculated in the degradation experiment in vitro: the concentration of PO4^3- from CPP during the degradation was determined by molybdenum blue photometric method: in leaching and degradation liquor, the growth curve of osteoblasts, RGR and toxicity grade was obtained respectively. RESULTS: The speed of degradation was γ-CPP〉β-CPP〉 α -CPP, which was consistent with the speed of the PO4^3- concentration increase. The growth rate of osteoblasts in the leaching liquor and degradation liquor of CPP with different crystal types was distinct, the highest value was observed in β-CPP at 6 days. The toxicity grade of α -CPP and β -CPP was 0, and the cell compatibility of γ-CPP was 0 at first and then turned to be 1. CONCLUSION: The degradation rate of CPP can be controllable by changing its crystal structure, and its favorable compatibility will enable CPP, especially β-CPP is the most effective to promote the proliferation of osteoblasts, thus it can be used as a novel bone repair material.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第32期6217-6220,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金项目(50472091) 四川大学大学生创新性实验计划国家级重点项目(049)~~
  • 相关文献

参考文献18

  • 1Boden SD. Biology of lumbar spine fusion and use of bone graft substitutes: present, future, and next generation. Tissue Eng 2000; 6(4):383-399
  • 2Pilliar RM, Filiaggi M J, Wells JD, et al . Porous calcium polyphosphate scaffold for bone substitute application in vitro characterization. Biomaterials 2001 ;22(9):963-972
  • 3Karen JL, Scott P, Jane FK. Biomaterial developments for bone tissue engineering. Biomaterials 2000; 21 (23): 2347-2359
  • 4Grynpas MD, Pilliar RM, Kandel RA, et al.Porous calcium polyphosphate scaffolds for bone substitute applications in vivo studies. Biomaterials 2002; 23(9):2063-2070
  • 5Yang L, Hong J Wang J, et al.Influence of anionic monomer content on the biodegradation and toxicity of polyvinyl-urethane carbonateceramic interpenetrating phase composites. Biomaterials 2005: 26(30): 5951-5959
  • 6Ciolfi V J. Pilliar R, McCulloch C, et aI.Chondrocyte interactions with porous titanium alloy and calcium polyphosphate substrates. Biomaterials 2003:24(26):4761-4770
  • 7Darla J. Hamilton, Cheryle A. Seguin, Jian Wang, et al. Formation of a nucleus pulposus-cartilage endplate construct in vitro. Biomaterials 2006; 27(3):397-405
  • 8Dion A, Langman M. Hall G. et al. Vancomycin release behaviour from amorphous carcium polyphosphate matrices intended for osteomyelitis treatment. Biomaterials 2005; 26(35): 7276-7285
  • 9Dion A, Langman M, Hall G, et al. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment. Biomaterials 2005: 26(21): 4486-4494
  • 10Porter NL. Pilliar RM. Grynpas MD. Fabrication of porous calcium polyphosphate implants by solid freeform fabrication: a study of processing parameters and in vitro degradation characteristics. J Biomed Mater Res 2001:56(4):504-515

二级参考文献21

  • 1姜作义,纤维-树脂复合材料新技术与应用,1990年,16页
  • 2戴树桂,环境化学,1989年,209页
  • 3团体著者,无机化学.下,1978年,151页
  • 4黄凤鸣 韩汗平 等.人发肌腱的实验研究与临床应用[J].中华实验外科杂志,1988,5:64-64.
  • 5Park EK, Lee YE, Choi JY,et al. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow derived stromal cells[J]. Biomaterials,2004,25(17):3403-3411.
  • 6Pilliar RM,Filiaggi MJ,Wells MD,et al.Porous calcium polyphosphate scaffolds for bone substitute applications -in vitro characterization[J]. Biomaterials, 2001, 22(9):963-972.
  • 7Yang SM,Kim SY,Lee SJ,et al.Tissue response of calcium polyphosphate in beagle dog[J].Key Engineering Materails, 2002,220(17):657-660.
  • 8QIU Kai, WAN Changxiu,CHEN Xin, et al. In vitro degradation studies of calcium polyphosphate ceramics prepared by controlled degree of polymerization and crystallization[J]. Key Engineering Materials,2005, 288-289:553-556.
  • 9Qiu Kai, Wan Changxiu, Tang Changwei, et al. Study on the degradation in vitro of calcium polyphosphate for bone tissue engineering[J]. Journal of Sichuan University (Engineering Science Edition),2005,37(1):25-29.
  • 10Min Wang.Developing bioactive composite materials for tissue replacemeng.Biomaterials,2003;24:2133

共引文献72

同被引文献41

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部